Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US Postal Service To Distribute Biden’s Free COVID-19 Rapid Antigen At-Home Tests Starting This Week

Executive Summary

Americans can order up to four rapid antigen tests per household through the USPS website now, or a phone hotline soon. The administration is working to buy another half a billion tests in the near future.

You may also be interested in...



Biden Announces New Direction For COVID-19 Policy In Annual Address

Proposals in the speech that could affect the device industry include “one-stop shops” for COVID-19 testing and treatment, additional funding to stockpile tests and masks, and a new government center devoted to health care research.

Biden Pledges A Billion COVID-19 Tests, Announces Plan Requiring Private Insurers To Pay For At-Home Diagnostics

The Biden administration announced on 13 January that it’s purchasing an additional 500 million COVID-19 tests to be distributed free to any American wanting one, bringing the total to 1 billion tests procured. 

Industry Urged White House To Invest In COVID-19 Tests Long Before Current Shortage: AdvaMed

The lobby group says the takeaway from the test shortage is the government should engage industry to prepare and ramp up test production before the next wave of variant infections in the ongoing pandemic.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT144958

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel